Virus injection targets liver tumors in early trial
NCT ID NCT00629759
First seen May 22, 2026 · Last updated May 22, 2026
Summary
This early-phase study tested a new treatment called JX-594, a modified virus injected directly into liver tumors. The main goal was to find a safe dose and check for side effects in 14 patients with advanced liver cancer that had not responded to standard treatments. The study focused on safety and how the body reacts to the virus, not on curing the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEOPLASMS, LIVER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dong-A University Hospital
Busan, 602-715, South Korea
Conditions
Explore the condition pages connected to this study.